“New developments in oncology in Lausanne“ by Prof. Coukos, C-Suite conference, May 19th, Hôtel Aquatis, Biopôle

“New developments in oncology in Lausanne“ by Prof. Coukos, C-Suite conference, May 19th, Hôtel Aquatis, Biopôle

While cancer is a long recognized disease, oncology can be perceived as a relatively modern specialty. In the more recent years, the oncology landscape has dramatically evolved thanks to major development in some key fields such as personalized medicine and genomics, innovative treatments like immunotherapy, vaccines, or also highly performant diagnostics procedures.

However, cancer is still responsible for 8.2 million deaths per year worldwide, with 14.1 million new cases every year and figures among the leading causes of morbidity and mortality worldwide. So, what are the latest trends in oncolgy, in which direction this very hot field is moving, what is driving innovation in the field and how does our region compare with other areas in the world in this particular arena?

These are some of the questions which will be addressed by experts, on the occasion of the next C-Suite to be held at Biopôle in Lausanne (Aquatis), on May 19th 2016. This new C-Suite conference will be the occasion for participants to listen to renown experts, namely Prof. George Coukos, who will shade light on those questions and share their perspectives on the evolution, and revolution, in oncology from the past and towards a promising future.

As usual, this C-Suite will be a mixture of short talks, lively roundtable and networking opportunities dedicated to a selective CXOs audience.

Provisional Program:

17h00 – 17h30 Registrations

Prof. George Coukos, “New developments in oncology in Lausanne “
Dr. Madiha Derouazi (CEO) Amal therapeutics
Dr. Nils Eckardt (Head of Medical Affairs), Ariad pharmaceuticals.
EY, Perspectives of the oncology market

– Round Table

19h00 Networking cocktail

Plus

Register

Leave a reply